Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
finasteride 3-oxo-5-beta-steroid 4-dehydrogenase small molecule NA drugbank , DGIDB Operative Surgical Procedures[MeSHID:D013514]
Urinary Retention[MeSHID:D016055]
Androgenetic Alopecia[MeSHID:D000505]
Prostate[MeSHID:D011467]
Benign Prostatic Hyperplasia[MeSHID:D011470]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 9.79 approved inhibitor
finasteride 3-oxo-5-alpha-steroid 4-dehydrogenase 1 small molecule NA drugbank , DGIDB Operative Surgical Procedures[MeSHID:D013514]
Urinary Retention[MeSHID:D016055]
Androgenetic Alopecia[MeSHID:D000505]
Prostate[MeSHID:D011467]
Benign Prostatic Hyperplasia[MeSHID:D011470]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 6.85 approved inhibitor
finasteride steroid 5-alpha-reductase 2 NA Successful target TTD , DGIDB Operative Surgical Procedures[MeSHID:D013514]
Urinary Retention[MeSHID:D016055]
Androgenetic Alopecia[MeSHID:D000505]
Prostate[MeSHID:D011467]
Benign Prostatic Hyperplasia[MeSHID:D011470]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 26.93 approved unknown
finasteride steroid 5-alpha-reductase 2 NA Successful target TTD , DGIDB Operative Surgical Procedures[MeSHID:D013514]
Urinary Retention[MeSHID:D016055]
Androgenetic Alopecia[MeSHID:D000505]
Prostate[MeSHID:D011467]
Benign Prostatic Hyperplasia[MeSHID:D011470]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 26.93 approved inhibitor
finasteride 3-oxo-5-alpha-steroid 4-dehydrogenase 2 small molecule NA drugbank , DGIDB Operative Surgical Procedures[MeSHID:D013514]
Urinary Retention[MeSHID:D016055]
Androgenetic Alopecia[MeSHID:D000505]
Prostate[MeSHID:D011467]
Benign Prostatic Hyperplasia[MeSHID:D011470]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 26.93 approved inhibitor
click here to return to the previous page